Related Experiment Video
Updated: May 17, 2026

Magnetic Resonance Imaging Quantification of Pulmonary Perfusion using Calibrated Arterial Spin Labeling
Published on: May 30, 2011
Magnetic resonance imaging contrast agent related pulmonary edema: a case report
A Demirhan1, U Yasar Tekelioglu, A Akkaya
1Department of Anesthesiology and Reanimation, Abant Izzet Baysal, University Medical School, Bolu, Turkey. dr_demirhan1@hotmail.com
Abstract:
Gadobutrol is a contrast agent often used during magnetic resonance imaging (MRI). The agent has several side effects, some of which can be serious. It has extremely rare life-threatening systemic complications, which can lead to bronchospasm, hypersensitivity reactions and cardiovascular arrest. However, there is no data available on the development of noncardiogenic pulmonary edema following use of gadobutrol. This paper examines the case of a 37-year-old male patient reported to have developed noncardiogenic pulmonary edema after intravenous injection of gadobutrol during MRI.
Insights
Gadobutrol, an MRI contrast agent, may rarely cause serious side effects. This case report details a patient who developed noncardiogenic pulmonary edema after gadobutrol administration.
Area of Science:
- Radiology and Medical Imaging
- Pharmacology and Toxicology
Background:
- Gadobutrol is a widely used gadolinium-based contrast agent for Magnetic Resonance Imaging (MRI).
- While generally safe, gadobutrol can cause rare but severe systemic complications.
- Existing literature lacks data on noncardiogenic pulmonary edema as a potential side effect.
Observation:
- A case study involving a 37-year-old male patient is presented.
- The patient received an intravenous injection of gadobutrol for an MRI procedure.
- Following the procedure, the patient developed noncardiogenic pulmonary edema.
Findings:
- This report documents the first known instance of noncardiogenic pulmonary edema after gadobutrol administration.
- The adverse event occurred in the context of standard MRI contrast agent use.
Implications:
- This finding suggests a previously unrecognized potential adverse effect of gadobutrol.
- Further research is warranted to investigate the mechanism and incidence of this complication.
- Clinicians should be aware of this potential risk when administering gadobutrol.
Related Concept Videos
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
Pulmonary Edema II: Pathophysiology
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System IV: CMRI
Magnetic Resonance Imaging
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

